The chance of getting HIV from a single exposure is lower than most people assume, but it varies dramatically depending on the type of contact. Receptive anal sex carries the highest sexual transmission risk at roughly 1 in 72 per act, while insertive vaginal sex sits at roughly 1 in 2,500. These numbers assume no condoms, no preventive medication, and a partner with a detectable viral load. With modern prevention tools, the actual risk drops close to zero.
Risk by Type of Sexual Contact
Not all sex acts carry the same HIV risk. The CDC estimates per-act transmission probabilities assuming an HIV-negative person has sex with an HIV-positive partner who is not on treatment and no condom is used:
- Receptive anal sex: about 138 per 10,000 acts, or 1 in 72
- Insertive anal sex: about 11 per 10,000 acts, or 1 in 909
- Receptive vaginal sex: about 8 per 10,000 acts, or 1 in 1,250
- Insertive vaginal sex: about 4 per 10,000 acts, or 1 in 2,500
Receptive anal sex is by far the highest-risk sexual activity because the lining of the rectum is thin and easily damaged, giving the virus direct access to the bloodstream. Vaginal sex carries a lower per-act risk, but over many exposures the cumulative probability rises. Oral sex carries a risk so low it’s difficult to measure in studies and is generally considered negligible.
These are averages. In any individual encounter, the real risk could be higher or lower depending on several biological factors covered below.
What Pushes the Risk Higher
The single biggest factor is viral load, the amount of virus circulating in the HIV-positive partner’s blood. During the acute phase of infection (the first 2 to 4 weeks after someone contracts HIV), viral load spikes to extremely high levels. Many people don’t know they’ve been infected yet, which makes this period especially dangerous for transmission. Without treatment, viral load can remain high indefinitely.
Having another sexually transmitted infection also increases risk on both sides of the equation. STIs that cause open sores, like herpes or syphilis, create direct entry points for HIV. Even STIs that cause inflammation without visible sores can recruit the immune cells that HIV targets, making transmission more efficient.
Circumcision status matters for the insertive partner in vaginal sex. The World Health Organization endorsed voluntary male circumcision for HIV prevention after studies showed it reduced female-to-male transmission by approximately 60%. The inner foreskin contains a high concentration of cells that HIV can infect, so removing it lowers (but does not eliminate) risk.
What Lowers the Risk Substantially
Three tools can reduce HIV transmission risk by enormous margins, and they work even better in combination.
Condoms reduce heterosexual HIV transmission by an estimated 87% with typical use, with effectiveness ranging from about 60% to 96% depending on how consistently and correctly they’re used. The wide range reflects real-world behavior: condoms that slip, break, or get skipped occasionally offer less protection than condoms used perfectly every time.
PrEP (pre-exposure prophylaxis) is a daily medication taken by the HIV-negative partner. When taken as prescribed, PrEP reduces the risk of getting HIV from sex by about 99%. For people who inject drugs, PrEP reduces risk by at least 74%. Injectable PrEP, given every two months, removes the need to remember a daily pill and has shown similarly high effectiveness.
Undetectable viral load may be the most powerful factor of all. When someone living with HIV takes treatment consistently and achieves an undetectable viral load, they effectively cannot transmit the virus sexually. This is sometimes summarized as “undetectable equals untransmittable,” or U=U. It means the per-act risk numbers above only apply when the positive partner is not on effective treatment.
Risk From Needle Sharing and Other Exposures
Sharing needles or syringes during injection drug use is one of the most efficient ways HIV spreads, with per-act risk estimates significantly higher than most sexual exposures. Blood remaining in a used needle can carry large amounts of virus directly into the bloodstream. Using sterile equipment every time, or accessing a syringe services program, eliminates this route.
Occupational exposures, like a healthcare worker getting stuck with a contaminated needle, carry a much lower risk, roughly 0.23% per incident. Casual contact, sharing food, kissing, swimming pools, toilet seats, and insect bites do not transmit HIV. The virus is fragile outside the body and cannot survive in these environments.
If You Think You Were Exposed
PEP (post-exposure prophylaxis) is a 28-day course of HIV medication that can prevent infection after a potential exposure. It must be started within 72 hours, and the sooner the better. The original study of PEP in healthcare settings showed an 81% reduction in infection among those who received treatment compared to those who didn’t. PEP is available through emergency rooms and many urgent care clinics.
After a potential exposure, testing is the only way to know your status, but timing matters because of the window period. A nucleic acid test (NAT), which looks for the virus itself, can detect HIV 10 to 33 days after exposure. An antigen/antibody lab test using blood drawn from a vein can detect infection 18 to 45 days after exposure. Rapid finger-stick tests and standard antibody tests have longer window periods, up to 90 days. Testing before the window period closes can produce a false negative, so a follow-up test is important if the initial result is negative but the exposure was recent.
Putting the Numbers in Perspective
The per-act risk numbers can feel reassuring in isolation, but they deserve context. A 1-in-1,250 chance per act of receptive vaginal sex sounds small, but over 100 unprotected encounters with an untreated partner, the cumulative probability climbs to roughly 8%. For receptive anal sex at 1 in 72, the cumulative risk after just 10 exposures reaches about 13%. Risk compounds with repeated exposure, which is why prevention strategies matter even when any single encounter seems low-risk.
The practical takeaway: if your partner is on effective HIV treatment with an undetectable viral load, the risk is essentially zero. If their status is unknown, condoms and PrEP together reduce the per-act risk by well over 99%. HIV transmission in 2024 is almost entirely preventable with the tools currently available.